National variation in pulmonary metastasectomy for colorectal cancer.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
06 2021
Historique:
revised: 17 11 2020
received: 09 09 2020
accepted: 04 12 2020
pubmed: 29 12 2020
medline: 4 9 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Evidence on patterns of use of pulmonary metastasectomy in colorectal cancer patients is limited. This population-based study aims to investigate the use of pulmonary metastasectomy in the colorectal cancer population across the English National Health Service (NHS) and quantify the extent of any variations in practice and outcome. All adults who underwent a major resection for colorectal cancer in an NHS hospital between 2005 and 2013 were identified in the COloRECTal cancer data Repository (CORECT-R). All inpatient episodes corresponding to pulmonary metastasectomy, occurring within 3 years of the initial colorectal resection, were identified. Multi-level logistic regression was used to determine patient and organizational factors associated with the use of pulmonary metastasectomy for colorectal cancer, and Kaplan-Meier and Cox models were used to assess survival following pulmonary metastasectomy. In all, 173 354 individuals had a major colorectal resection over the study period, with 3434 (2.0%) undergoing pulmonary resection within 3 years. The frequency of pulmonary metastasectomy increased from 1.2% of patients undergoing major colorectal resection in 2005 to 2.3% in 2013. Significant variation was observed across hospital providers in the risk-adjusted rates of pulmonary metastasectomy (0.0%-6.8% of patients). Overall 5-year survival following pulmonary resection was 50.8%, with 30-day and 90-day mortality of 0.6% and 1.2% respectively. This study shows significant variation in the rates of pulmonary metastasectomy for colorectal cancer across the English NHS.

Identifiants

pubmed: 33368958
doi: 10.1111/codi.15506
pmc: PMC8614123
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1306-1316

Subventions

Organisme : Cancer Research UK
ID : A23706
Pays : United Kingdom
Organisme : Yorkshire Cancer Research
ID : L394
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.

Références

Ann Thorac Surg. 2019 Feb;107(2):631-649
pubmed: 30476477
J Thorac Cardiovasc Surg. 1997 Jan;113(1):37-49
pubmed: 9011700
Thorax. 2011 Dec;66(12):1078-84
pubmed: 21785158
Sci Rep. 2016 Jul 15;6:29765
pubmed: 27416752
BMJ Open. 2013 May 28;3(5):
pubmed: 23793698
Colorectal Dis. 2021 Jan;23(1):200-205
pubmed: 33002305
Int J Colorectal Dis. 2011 Feb;26(2):183-90
pubmed: 20960207
Eur J Cardiothorac Surg. 2017 May 1;51(5):869-873
pubmed: 28369355
Ann Oncol. 2014 Mar;25(3):651-657
pubmed: 24504447
Colorectal Dis. 2014 Dec;16(12):965-70
pubmed: 25284641
J Thorac Dis. 2017 Oct;9(Suppl 12):S1282-S1290
pubmed: 29119016
Cancer. 2015 Mar 1;121(5):747-57
pubmed: 25377689
Ann Thorac Surg. 2009 Jun;87(6):1684-8
pubmed: 19463577
Dis Colon Rectum. 2012 Apr;55(4):459-64
pubmed: 22426271
Ann Surg Oncol. 2013 Apr;20(4):1374-80
pubmed: 23196787
Eur J Cardiothorac Surg. 2007 Feb;31(2):167-72
pubmed: 17150367
Oncologist. 2012;17(11):1430-8
pubmed: 22956535
Thorax. 2019 Jan;74(1):51-59
pubmed: 30100577
Br J Surg. 2009 Sep;96(9):1058-65
pubmed: 19672932
Ann Thorac Surg. 2010 Feb;89(2):375-80
pubmed: 20103301
Colorectal Dis. 2020 Oct;22(10):1314-1324
pubmed: 32388895
Ann Surg Oncol. 2006 Nov;13(11):1538-44
pubmed: 17009154
BMJ Open. 2018 Feb 17;8(2):e019614
pubmed: 29455167
Lancet. 2019 May 18;393(10185):2051-2058
pubmed: 30982687
Br J Surg. 2017 Jun;104(7):918-925
pubmed: 28251644
J Clin Oncol. 2013 Sep 1;31(25):3141-6
pubmed: 23897962
J Gastrointest Surg. 2009 Apr;13(4):642-8
pubmed: 19082673
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376151
Ann Surg. 2019 Nov;270(5):892-898
pubmed: 31567507
Thorac Surg Clin. 2016 Feb;26(1):7-12
pubmed: 26611505
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
Stat Med. 2005 Apr 30;24(8):1185-202
pubmed: 15568194

Auteurs

Hayley M Fenton (HM)

Cancer Epidemiology Group, Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.

Paul J Finan (PJ)

Cancer Epidemiology Group, Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.

Richard Milton (R)

Department of Thoracic Surgery, St James's University Hospital, Leeds, UK.

Michael Shackcloth (M)

Department of Thoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK.

John C Taylor (JC)

Cancer Epidemiology Group, Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.

Tom Treasure (T)

Clinical Operational Research Unit, University College London, London, UK.

Eva J A Morris (EJA)

Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH